Terms: = Germ cell tumor AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037
4939 results:
1. Long-term outcomes of neuroendoscopic cyst partial resection combined with stereotactic radiotherapy for craniopharyngioma.
Fukuhara N; Nishihara T; Sato K; Inoshita N; Tatsushima K; Yamaguchi-Okada M; Ishojima T; Takeshita A; Ito J; Takeuchi Y; Yamada S; Nishioka H
Acta Neurochir (Wien); 2024 May; 166(1):218. PubMed ID: 38750340
[TBL] [Abstract] [Full Text] [Related]
2. ReMIND: The Brain Resection Multimodal Imaging Database.
Juvekar P; Dorent R; Kögl F; Torio E; Barr C; Rigolo L; Galvin C; Jowkar N; Kazi A; Haouchine N; Cheema H; Navab N; Pieper S; Wells WM; Bi WL; Golby A; Frisken S; Kapur T
Sci Data; 2024 May; 11(1):494. PubMed ID: 38744868
[TBL] [Abstract] [Full Text] [Related]
3. Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world data.
Moser JC; Bhatia S; Amin A; Pavlick AC; Betts KA; Du EX; Poretta T; Shelley K; Srinivasan S; Sakkal LA; Palaia J; Lobo M; Pe Benito M; Linton JA; Chen Y; Xu C; Yin L; Sundar M; Weber J
Cancer Immunol Immunother; 2024 May; 73(7):116. PubMed ID: 38713408
[TBL] [Abstract] [Full Text] [Related]
4. Quercetin Impairs the Growth of Uveal Melanoma cells by Interfering with Glucose Uptake and Metabolism.
Tura A; Herfs V; Maaßen T; Zuo H; Vardanyan S; Prasuhn M; Ranjbar M; Kakkassery V; Grisanti S
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673877
[TBL] [Abstract] [Full Text] [Related]
5. A qualitative evaluation of factors influencing tumor Treating fields (TTFields) therapy decision making among brain tumor patients and physicians.
Kumthekar P; Lyleroehr M; Lacson L; Lukas RV; Dixit K; Stupp R; Kruser T; Raizer J; Hou A; Sachdev S; Schwartz M; Pa JB; Lezon R; Schmidt K; Amidei C; Kaiser K
BMC Cancer; 2024 Apr; 24(1):527. PubMed ID: 38664630
[TBL] [Abstract] [Full Text] [Related]
6. Temporal lobe injury with middle fossa approach to intracanalicular vestibular schwannomas: a systematic review.
Flores-Milan G; Rainone GJ; Piper K; Peto I; Danner C; Allen KP; Liu SS; van Loveren H; Agazzi S
Neurosurg Rev; 2024 Apr; 47(1):188. PubMed ID: 38658423
[TBL] [Abstract] [Full Text] [Related]
7. Clinical Presentation, Management, and Diagnostic Performance of 2021 Criteria for Paraneoplastic Neurologic Syndromes in Childhood.
Zhou J; Jin M; Su Y; Zhuo X; Fu L; Ren X; Ren C; Zhou A; Li J; Zhang W
Neurol Neuroimmunol Neuroinflamm; 2024 May; 11(3):e200242. PubMed ID: 38657195
[TBL] [Abstract] [Full Text] [Related]
8. Laser interstitial thermal therapy for recurrent glioblastomas: a systematic review and meta-analysis.
Zhao X; Li R; Guo Y; Wan H; Zhou D
Neurosurg Rev; 2024 Apr; 47(1):159. PubMed ID: 38625588
[TBL] [Abstract] [Full Text] [Related]
9. How does deep learning/machine learning perform in comparison to radiologists in distinguishing glioblastomas (or grade IV astrocytomas) from primary CNS lymphomas?: a meta-analysis and systematic review.
Guha A; Halder S; Shinde SH; Gawde J; Munnolli S; Talole S; Goda JS
Clin Radiol; 2024 Jun; 79(6):460-472. PubMed ID: 38614870
[TBL] [Abstract] [Full Text] [Related]
10. Correlation of
Ueda CE; Flausino Dias L; de Godoi Carneiro C; Sapienza MT; Alberto Buchpiguel C; Schiavom Duarte P
Arch Endocrinol Metab; 2024 Apr; 68():e230152. PubMed ID: 38602746
[TBL] [Abstract] [Full Text] [Related]
11. Uveal melanoma cell lines Mel270 and 92.1 exhibit a mesenchymal phenotype and sensitivity to the cytostatic effects of transforming growth factor beta in vitro.
Doudnikoff C; Leclerc D; Angenard G; Gilot D; Coulouarn C; Mouriaux F
Mol Vis; 2024; 30():160-166. PubMed ID: 38601020
[TBL] [Abstract] [Full Text] [Related]
12. [Bilateral synchronous anaplastic variant spermatocytic tumor: Report of a rare neoplasm].
Sarabia Ochoa R; García de la Torre JP
Rev Esp Patol; 2024; 57(2):146-150. PubMed ID: 38599737
[TBL] [Abstract] [Full Text] [Related]
13. Characteristics of long-survivor metastatic melanoma after polychemotherapy and interferon: a retrospective study.
Py C; De Vito C; Tsantoulis P; Kaya G; Labidi-Galy SI; Dietrich PY
Swiss Med Wkly; 2023 Dec; 153():3504. PubMed ID: 38579317
[TBL] [Abstract] [Full Text] [Related]
14. Clinical and radiological features of intracranial ancient schwannomas: a single-institution, retrospective analysis.
Tsuchiya T; Ikemura M; Miyawaki S; Teranishi Y; Ohara K; Ushiku T; Saito N
Brain Tumor Pathol; 2024 Apr; 41(2):73-79. PubMed ID: 38578531
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic value of preoperative diffusion restriction in glioblastoma.
Labbène E; Mahmoud M; Marrakchi-Kacem L; Ben Hamouda M
Tunis Med; 2024 Feb; 102(2):94-99. PubMed ID: 38567475
[TBL] [Abstract] [Full Text] [Related]
16. Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium.
Bührer E; D'Haese D; Daugaard G; de Wit R; Albany C; Tryakin A; Fizazi K; Stahl O; Gietema JA; De Giorgi U; Cafferty FH; Hansen AR; Tandstad T; Huddart RA; Necchi A; Sweeney CJ; Garcia-Del-Muro X; Heng DYC; Lorch A; Chovanec M; Winquist E; Grimison P; Feldman DR; Terbuch A; Hentrich M; Bokemeyer C; Negaard H; Fankhauser C; Shamash J; Vaughn DJ; Sternberg CN; Heidenreich A; Collette L; Gillessen S; Beyer J
Eur J Cancer; 2024 May; 202():114042. PubMed ID: 38564927
[TBL] [Abstract] [Full Text] [Related]
17. Volumetric Response and Survival of Patients With Bulky IDH-Mutated Grade 3 Glioma Managed With FET-FDG-Guided Integrated Boost IMRT.
Mills D; Horsley P; Venkatasha V; Back M
Clin Oncol (R Coll Radiol); 2024 Jun; 36(6):343-352. PubMed ID: 38553362
[TBL] [Abstract] [Full Text] [Related]
18. Advancing glioma diagnosis: Integrating custom U-Net and VGG-16 for improved grading in MR imaging.
Saluja S; Trivedi MC; Sarangdevot SS
Math Biosci Eng; 2024 Feb; 21(3):4328-4350. PubMed ID: 38549330
[TBL] [Abstract] [Full Text] [Related]
19. Performance of an automated total body mapping algorithm to detect melanocytic lesions of clinical relevance.
Winkler JK; Kommoss KS; Toberer F; Enk A; Maul LV; Navarini AA; Hudson J; Salerni G; Rosenberger A; Haenssle HA
Eur J Cancer; 2024 May; 202():114026. PubMed ID: 38547776
[TBL] [Abstract] [Full Text] [Related]
20. A three-arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma.
Sacco JJ; Jackson R; Corrie P; Danson S; Evans TRJ; Ochsenreither S; Kumar S; Goodman A; Larkin J; Karydis I; Steven N; Lorigan P; Plummer R; Patel P; Psarelli E; Olsson-Brown A; Shaw H; Leyvraz S; Handley L; Rawcliffe C; Nathan P
Eur J Cancer; 2024 May; 202():114009. PubMed ID: 38547774
[TBL] [Abstract] [Full Text] [Related]
[Next]
